CARMA: ready to analyze samples from 1st patient enrolled

22 Sep, 2017

Samples from first CARMA patient enrolled at Imperial College Healthcare NHS Trust in London arrive in University College London Lab!


CARMA is a a multi-centre, cross-sectional study of children with perinatally acquired HIV-1 on sustained suppressive antiretroviral therapy started before 2 years of age. It is part of the EPIICAL study (Early treated Perinatally HIV Infected individuals: Improving Children’s Actual Life) , which is financed by ViiV Healthcare U.K. (ViiV).